CELZ
Price
$3.18
Change
+$0.02 (+0.63%)
Updated
Aug 29 closing price
Capitalization
8.21M
CRSP
Price
$51.83
Change
-$1.22 (-2.30%)
Updated
Aug 29 closing price
Capitalization
4.71B
60 days until earnings call
Interact to see
Advertisement

CELZ vs CRSP

Header iconCELZ vs CRSP Comparison
Open Charts CELZ vs CRSPBanner chart's image
Creative Medical Technology Holdings
Price$3.18
Change+$0.02 (+0.63%)
Volume$25.5K
Capitalization8.21M
CRISPR Therapeutics AG
Price$51.83
Change-$1.22 (-2.30%)
Volume$1.59M
Capitalization4.71B
CELZ vs CRSP Comparison Chart in %
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. CRSP commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (CELZ: $3.16 vs. CRSP: $51.83)
Brand notoriety: CELZ and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 17% vs. CRSP: 49%
Market capitalization -- CELZ: $8.21M vs. CRSP: $4.71B
CELZ [@Biotechnology] is valued at $8.21M. CRSP’s [@Biotechnology] market capitalization is $4.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than CELZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 2 bullish TA indicator(s).

  • CELZ’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, CELZ is a better buy in the short-term than CRSP.

Price Growth

CELZ (@Biotechnology) experienced а 0.00% price change this week, while CRSP (@Biotechnology) price change was -4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

CRSP is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.71B) has a higher market cap than CELZ($8.21M). CELZ YTD gains are higher at: 37.662 vs. CRSP (31.682). CELZ has higher annual earnings (EBITDA): -5.81M vs. CRSP (-533.5M). CRSP has more cash in the bank: 1.72B vs. CELZ (6.54M). CELZ has less debt than CRSP: CELZ (2.74M) vs CRSP (215M). CRSP has higher revenues than CELZ: CRSP (35M) vs CELZ (6K).
CELZCRSPCELZ / CRSP
Capitalization8.21M4.71B0%
EBITDA-5.81M-533.5M1%
Gain YTD37.66231.682119%
P/E RatioN/AN/A-
Revenue6K35M0%
Total Cash6.54M1.72B0%
Total Debt2.74M215M1%
FUNDAMENTALS RATINGS
CELZ vs CRSP: Fundamental Ratings
CELZ
CRSP
OUTLOOK RATING
1..100
2666
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4546
P/E GROWTH RATING
1..100
5979
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (64) in the Biotechnology industry is in the same range as CELZ (79) in the null industry. This means that CRSP’s stock grew similarly to CELZ’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CELZ (100) in the null industry. This means that CRSP’s stock grew similarly to CELZ’s over the last 12 months.

CRSP's SMR Rating (96) in the Biotechnology industry is in the same range as CELZ (98) in the null industry. This means that CRSP’s stock grew similarly to CELZ’s over the last 12 months.

CELZ's Price Growth Rating (45) in the null industry is in the same range as CRSP (46) in the Biotechnology industry. This means that CELZ’s stock grew similarly to CRSP’s over the last 12 months.

CELZ's P/E Growth Rating (59) in the null industry is in the same range as CRSP (79) in the Biotechnology industry. This means that CELZ’s stock grew similarly to CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZCRSP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSPIX104.39N/A
N/A
SEI S&P 500 Index F (SIMT)
CDIRX36.08N/A
N/A
Columbia Dividend Income R
FBMCX12.62N/A
N/A
Franklin Managed Income C
MSEIX82.25N/A
N/A
AMG Veritas Asia Pacific I
GSBDX16.39N/A
N/A
Goldman Sachs Small Cap Growth A

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
+0.63%
LABFF - CELZ
35%
Loosely correlated
N/A
RARE - CELZ
33%
Poorly correlated
-1.12%
MREO - CELZ
32%
Poorly correlated
-2.29%
WVE - CELZ
30%
Poorly correlated
-3.32%
CRSP - CELZ
29%
Poorly correlated
-2.30%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.30%
RXRX - CRSP
69%
Closely correlated
-3.39%
BEAM - CRSP
67%
Closely correlated
-2.91%
NTLA - CRSP
63%
Loosely correlated
-2.11%
CRBU - CRSP
59%
Loosely correlated
-3.61%
PRME - CRSP
58%
Loosely correlated
-5.81%
More